Literature DB >> 21631404

Neuroinflamm-aging and neurodegenerative diseases: an overview.

Vincenzo Pizza1, Anella Agresta, Cosimo W D'Acunto, Michela Festa, Anna Capasso.   

Abstract

Neuroinflammation is considered a chronic activation of the immune response in the central nervous system (CNS) in response to different injuries. This brain immune activation results in various events: circulating immune cells infiltrate the CNS; resident cells are activated; and pro-inflammatory mediators produced and released induce neuroinflammatory brain disease. The effect of immune diffusible mediators on synaptic plasticity might result in CNS dysfunction during neuroinflammatory brain diseases. The CNS dysfunction may induce several human pathological conditions associated with both cognitive impairment and a variable degree of neuroinflammation. Furthermore, age has a powerful effect on enhanced susceptibility to neurodegenerative diseases and age-dependent enhanced neuroinflammatory processes may play an important role in toxin generation that causes death or dysfunction of neurons in neurodegenerative diseases This review will address current understanding of the relationship between ageing, neuroinflammation and neurodegenerative disease by focusing on the principal mechanisms by which the immune system influences the brain plastic phenomena. Also, the present review considers the principal human neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis and psychiatric disorders caused by aging and neuroinflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631404     DOI: 10.2174/187152711796235014

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  43 in total

1.  Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation.

Authors:  Bevyn Jarrott; Spencer J Williams
Journal:  Neurochem Res       Date:  2015-07-16       Impact factor: 3.996

Review 2.  The role of inflammasome in Alzheimer's disease.

Authors:  Li Liu; Christina Chan
Journal:  Ageing Res Rev       Date:  2014-02-19       Impact factor: 10.895

3.  Silibinin ameliorates Aβ25-35-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress.

Authors:  Xiaoyu Song; Biao Zhou; Lingyu Cui; Di Lei; Pingping Zhang; Guodong Yao; Mingyu Xia; Toshihiko Hayashi; Shunji Hattori; Yuko Ushiki-Kaku; Shin-Ichi Tashiro; Satoshi Onodera; Takashi Ikejima
Journal:  Neurochem Res       Date:  2016-12-22       Impact factor: 3.996

4.  Protective Effect of Silibinin on Learning and Memory Impairment in LPS-Treated Rats via ROS-BDNF-TrkB Pathway.

Authors:  Xiaoyu Song; Biao Zhou; Pingping Zhang; Di Lei; Yubin Wang; Guodong Yao; Toshihiko Hayashi; Mingyu Xia; Shin-Ichi Tashiro; Satoshi Onodera; Takashi Ikejima
Journal:  Neurochem Res       Date:  2016-03-09       Impact factor: 3.996

Review 5.  Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease.

Authors:  Maire E Percy; Theo P A Kruck; Aileen I Pogue; Walter J Lukiw
Journal:  J Inorg Biochem       Date:  2011-08-19       Impact factor: 4.155

Review 6.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

7.  Neuroprotective effect of diclofenac on chlorpromazine induced catalepsy in rats.

Authors:  Sadaf Naeem; Rahila Najam; Saira Saeed Khan; Talat Mirza; Bushra Sikandar
Journal:  Metab Brain Dis       Date:  2019-05-04       Impact factor: 3.584

8.  Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders.

Authors:  Jose A Morales-Garcia; Valle Palomo; Miriam Redondo; Sandra Alonso-Gil; Carmen Gil; Ana Martinez; Ana Perez-Castillo
Journal:  ACS Chem Neurosci       Date:  2014-01-17       Impact factor: 4.418

9.  Gas1 Knockdown Increases the Neuroprotective Effect of Glial Cell-Derived Neurotrophic Factor Against Glutamate-Induced Cell Injury in Human SH-SY5Y Neuroblastoma Cells.

Authors:  Ke Wang; Xue Zhu; Kai Zhang; Fanfan Zhou; Ling Zhu
Journal:  Cell Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.046

Review 10.  CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways.

Authors:  Seyed Mohammad Gheibihayat; Ricardo Cabezas; Nikita G Nikiforov; Tannaz Jamialahmadi; Thomas P Johnston; Amirhossein Sahebkar
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.